期刊文献+

2015~2016年无锡市疑似预防接种异常反应监测分析 被引量:17

Surveillance and analysis of adverse events following immunization in Wuxi City,Jiangsu Province,China during 2015~2016
原文传递
导出
摘要 目的分析无锡市2015~2016年疑似预防接种异常反应的特征,评价系统运行情况,提出针对性改善预防接种质量的措施,为疫苗安全性评价提供科学依据。方法收集2015~2016年无锡市报告的AEFI个案数据,采用描述性流行病学方法进行分析。结果 2015~2016年,无锡市AEFI监测系统共收集到2 397例个案报告,报告发生率为69.12/10万剂,其中一般反应占85.6%,以发热、红肿、硬结为主,异常反应以过敏性皮疹为主,89.7%的AEFI发生在接种1 d内,AEFI发生率较高的疫苗为无细胞百白破(145.11/10万剂)、含麻类疫苗(115.59/万剂)。结论无锡市2015~2016年疫苗AEFI发生率低,临床症状轻,疫苗安全性较好。AEFI监测系统运行成熟,数据质量较好。 Objective To analyze the features of adverse events following immunization(AEFI) in Wuxi City,Jiangsu Province,China during 2015 ~ 2016,evaluate the implementation of AEFI surveillance system,take the measure to improve the quality of vaccination and provide a scientific basis for the safety evaluation of vaccine. Methods The data on AEFI in Wuxi during 2015 ~ 2016 were collected and analyzed by descriptive epidemiology. Results A total of 2 397 cases were collected in the monitoring system of AEFI in Wuxi during 2015 ~ 2016,indicating an incidence of 69. 12/100 000 doses,of which 85. 6% were common reactions such as fever,redness and induration. However,abnormal reactions were mainly allergic skin rash. A portion of 89. 7% of AEFI occurred within 1 d after immunization. Acellular DTP(145. 11/100 000 doses) and measles-containing vaccines(115. 59/100 000 doses) induced relatively high incidences of AEFI. Conclusion The incidence rate of AEFI was low in Wuxi City,while clinical symptoms were mild,indicating high safety of the vaccines. The AEFI monitoring system rans well and the data quality was good.
作者 蒋静凤 王旭雯 JIANG Jing-feng;WANG Xu-wen(Wuxi Center for Disease Control and prevention, Wuxi 21d023, Jiangsu Province, China)
出处 《中国生物制品学杂志》 CAS CSCD 2018年第6期629-632,共4页 Chinese Journal of Biologicals
关键词 疑似预防接种异常反应 监测 疫苗 报告 Adverse events following immunization (AEFI) Surveillance Vaccine Report
  • 相关文献

参考文献11

二级参考文献65

  • 1吴殚,王凤双,肖雷.北京市顺义区2008~2010年疑似预防接种异常反应监测分析[J].现代预防医学,2012,39(22):5969-5971. 被引量:16
  • 2卫生部.预防接种工作规范[M].2005.50-57. 被引量:3
  • 3卫生部.全国疑似预防接种异常反应监测方案[S].2010-06-03. 被引量:39
  • 4中华人民共和国卫生部.全国疑似预防接种异常反应监测方案[Z].2010. 被引量:11
  • 5卫生部办公厅,国家食品药品监督管理局办公室.全国疑似预防接种异常反应监测方案[S].北京:卫生部,2010. 被引量:6
  • 6卫生部.全国疑似预防接种异常反应监测方案[Z].2010-06-03. 被引量:14
  • 7www.wpro.who.int/china/areas/hepatitis/en/index.html. 被引量:1
  • 8www.who.int/immunization_monitoring/diseases/M NTE_initiative/ en/index4.html. 被引量:1
  • 9www.wpro.who.intJchina/mediacentre/releases/2012/20121129/en/. 被引量:1
  • 10Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to hepatitis B vaccination [ J 1. Vaccine, 2009;27:6550-6557. 被引量:1

共引文献136

同被引文献148

引证文献17

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部